Northwest Investment Counselors’s iShares Biotechnology ETF IBB Stock Holding History

Northwest Investment Counselors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$18.5K	Buy	+127	New	+$18.4K	﹤0.01%	357
2024 Q2	–	Sell	-127	Closed	-$17.4K	–	312
2024 Q1	$17.4K	Buy	+127	New	+$17.3K	﹤0.01%	327
2023 Q4	–	Sell	-127	Closed	-$15.5K	–	314
2023 Q3	$15.5K	Hold	127	–	–	﹤0.01%	338
2023 Q2	$16.1K	Hold	127	–	–	﹤0.01%	336
2023 Q1	$16.4K	Hold	127	–	–	﹤0.01%	350
2022 Q4	$16.7K	Sell	127 -250	-66%	-$32.3K	﹤0.01%	349
2022 Q3	$44K	Buy	377 +250	+197%	+$31K	0.01%	227
2022 Q2	$15K	Hold	127	–	–	﹤0.01%	324
2022 Q1	$17K	Buy	+127	New	+$16.5K	﹤0.01%	334
2021 Q2	–	Sell	-200	Closed	-$30K	–	275
2021 Q1	$30K	Buy	+200	New	+$31.8K	0.01%	265
2017 Q4	–	Sell	-300	Closed	-$33K	–	210
2017 Q3	$33K	Hold	300	–	–	0.01%	210
2017 Q2	$31K	Buy	+300	New	+$29.5K	0.01%	197

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Northwest Investment Counselors's IBB Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in iShares Biotechnology ETF (IBB) in Q3 2024: 127 shares worth $18.5K. The stake represents ﹤0.01% of the portfolio and ranks #357 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in IBB as recently as Q1 2024.

Northwest Investment Counselors first reported a position in IBB in Q2 2017 and has held it in 12 quarters since. The position peaked at $44K in Q3 2022. 894 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

Northwest Investment Counselors held 127 shares of iShares Biotechnology ETF worth $18.5K as of Q3 2024.
iShares Biotechnology ETF was a new Northwest Investment Counselors position in Q3 2024.
iShares Biotechnology ETF made up ﹤0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #357 holding.
Northwest Investment Counselors first reported a position in iShares Biotechnology ETF in Q2 2017 and has held it in 12 quarters since.
Northwest Investment Counselors's iShares Biotechnology ETF position peaked at $44K in Q3 2022.
894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.